Veramorph LLC is a Mansfield-based company that specializes in maximizing the therapeutic potential of poorly soluble small molecules. With their proprietary oral drug delivery platform, they assist companies in improving and expediting the clinical translation of poorly soluble lead compounds, while also building a portfolio of clinically-differentiated oral versions of approved drugs.
Led by a team of experienced entrepreneurs and executives with expertise in drug delivery and product design, Veramorph is actively seeking skilled chemists, engineers, and scientists to join their research and development team. Their platform technology has been accepted into the FDA Novel Excipient Review Program, further facilitating the regulatory pathway for their innovative drug delivery solutions.
Generated from the website